Last reviewed · How we verify
NCT03867669
Single Patient Room Versus Open Bay in NICU
NA trial testing Open Bay Unit in Neurodevelopmental Outcomes in 160 participants. Status unknown.
31 August 2019
Quick facts
| Lead sponsor | IWK Health Centre |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 160 |
| Start date | 11 April 2018 |
| Primary completion | 31 August 2019 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Open Bay Unit
- Single patient room
Conditions studied
- Neurodevelopmental Outcomes — all drugs for Neurodevelopmental Outcomes →
Sponsor
IWK Health Centre — full company profile →
Who can join
Under 14 Days, any sex, with Neurodevelopmental Outcomes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The NICU at the IWK Health Center in Halifax, Nova Scotia is embarking on a redevelopment project that will see its current open bay design converted to a single room care environment. There will be a period during the redevelopment when new single room care unit will coexist with one open bay unit. This provides a unique opportunity to explore the effect of the two different environmental designs on both short and long-term outcomes. Preterm infants (under 31 weeks gestational age) and very low birth weight infants (under 1500 grams) will be randomized to either the open bay unit or the single patient room unit, at 36 months corrected age neurodevelopmental outcomes will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03867669
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurodevelopmental Outcomes
Currently open trials in the same condition.
- NCT07203469 — Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth · NA · recruiting
- NCT05849077 — Optimization of Saturation Targets And Resuscitation Trial (OptiSTART) · NA · recruiting
Other IWK Health Centre trials
Trials by the same sponsor.
- NCT06797076 — App-Based Migraine Treatment: The Health enSuite Study · NA · not yet recruiting
- NCT07112430 — Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants · Phase 1, PHASE2 · not yet recruiting
- NCT07165782 — Brief Videos Delivered by Text Messages as a Public Health Intervention for PTSD in Youth · NA · recruiting
- NCT06968377 — The COVID Dome Trial · NA · not yet recruiting
- NCT07284329 — Examining the Efficacy of a Digital Media Intervention to Increase Recruitment Rates · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03867669 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IWK Health Centre
- Last refreshed: 8 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03867669.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing